DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Radiation Dose Management Market - Global Forecast to 2022" report to their offering.

The global radiation dose management market is estimated to grow at a CAGR of 42.0% from 2017 to 2022, to reach USD 931.3 million by 2022 from USD 161.3 million in 2017.

The growing adoption of EHR systems, increasing initiatives for the implementation of health information exchanges (HIEs), growing awareness on radiation safety, increasing radiation exposure to patients, and increasing number of diagnostic imaging exams across the globe are other factors driving the growth of the radiation dose management market. However, the lack of in-house education and training on radiation dose management, lack of understanding amongst physicians and technologists towards dose optimization approaches, and low adoption of radiation dose management solutions in emerging countries are some of the factors restraining the growth of this market.
In 2017, North America accounted for the largest share of the global radiation dose management market, followed by Europe, Asia-Pacific, and RoW. This is due to the presence of a large number of hospitals and health systems, changing regulations, increasing accreditation requirements, and the increasing need to curtail the soaring healthcare costs.

Companies Mentioned

Acquired By Canon Inc. (Japan)
Agfa Healthcare (Belgium)
Bayer AG (Germany)
Fujifilm Holding Corporation (Japan)
GE Healthcare (U.S.)
Medic Vision (U.S,)
Medint Holdings LLC (U.S.)
Medsquare (France)
Novarad Corporation (U.S.)
Pacshealth LLC (U.S.)
Philips ,Healthcare (Netherlands)
Qaelum N.V.(Belgium)
Sectra AB (Sweden)
Siemens Healthineers ( Germany)
Toshiba Medical Systems Corporation
Volpara Solutions Inc. (U.S.)
Bracco Imaging S.P.A. (Italy)

CT Homepage